Correlation Between Recursion Pharmaceuticals and 278642AY9
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and EBAY INC, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 278642AY9 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 278642AY9. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 278642AY9.
Diversification Opportunities for Recursion Pharmaceuticals and 278642AY9
-0.22 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Recursion and 278642AY9 is -0.22. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and EBAY INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 278642AY9 and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 278642AY9. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 278642AY9 has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 278642AY9 go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and 278642AY9
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 3.71 times more return on investment than 278642AY9. However, Recursion Pharmaceuticals is 3.71 times more volatile than EBAY INC. It trades about 0.07 of its potential returns per unit of risk. EBAY INC is currently generating about -0.06 per unit of risk. If you would invest 650.00 in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would earn a total of 107.00 from holding Recursion Pharmaceuticals or generate 16.46% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 96.88% |
Values | Daily Returns |
Recursion Pharmaceuticals vs. EBAY INC
Performance |
Timeline |
Recursion Pharmaceuticals |
278642AY9 |
Recursion Pharmaceuticals and 278642AY9 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Recursion Pharmaceuticals and 278642AY9
The main advantage of trading using opposite Recursion Pharmaceuticals and 278642AY9 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 278642AY9 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 278642AY9 will offset losses from the drop in 278642AY9's long position.Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
278642AY9 vs. AEP TEX INC | 278642AY9 vs. US BANK NATIONAL | 278642AY9 vs. Recursion Pharmaceuticals | 278642AY9 vs. Intuitive Machines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |